There is a peculiar contradiction at the center of how our culture talks about hormones. On one hand, women's emotions, decisions, and physical experiences are routinely dismissed as "just hormonal" — a phrase that implies irrationality, instability, and a body out of control. On the other hand, the hormonal transitions that profoundly affect women's health, cognition, skin, and wellbeing — puberty, the menstrual cycle, perimenopause, menopause — are systematically undertaught, underfunded, and underacknowledged in medical education and popular culture.

Men's hormones are barely discussed at all — as though testosterone, andropause, and the gradual hormonal changes of male aging are either irrelevant or too sensitive to address. And transgender individuals — whose deliberate hormonal transitions offer some of the clearest windows into what hormones actually do — are largely absent from the scientific literature that informs our understanding.

This series — Your Skin Through Every Stage — is built on a different premise: hormones are real, they matter in every body across every life stage, and understanding them is not reductive. It is empowering. This post is its foundation.

Hormonal literacy — a basic understanding of what hormones are, what they do, and how they change across a lifetime — is one of the most practically useful bodies of knowledge a person can have. It explains why skin behaves the way it does at different ages and life stages. It explains mood changes that would otherwise seem random. It contextualizes physical changes that are genuinely confusing without the biological framework to understand them. It enables informed conversations with healthcare providers. And it provides the foundation for making choices — about skincare, nutrition, lifestyle, and medical care — that are actually appropriate for where a body is rather than where it was a decade ago.

Most of us were not given this literacy. Biology classes covered hormones briefly and reductively — puberty, reproduction, and little else. The hormonal transitions of midlife, aging, and medical treatment were not part of the curriculum. The result is that the majority of adults are navigating profoundly hormonal experiences — perimenopause, andropause, thyroid dysfunction, cancer treatment — with almost no biological framework for understanding what is happening in their own bodies.

This is not a minor gap. It has consequences for health decisions, self-understanding, the quality of conversations with physicians, and the ability to recognize when something is genuinely wrong versus a normal biological transition. Closing this gap is what this series is for.

Here is the argument that some feminist frameworks have gotten wrong: pretending that biological differences between sexes do not exist, or that hormonal influences on human experience are not real, does not create equality. It creates ignorance — and ignorance that falls most heavily on women, whose health has historically been most poorly served by the medical establishment's failure to take hormonal biology seriously.

True equality is not achieved by pretending everyone's biology is identical. It is achieved by ensuring that everyone's biology is equally understood, equally funded in research, and equally acknowledged in medical care.

Women who understand what perimenopause is doing to their brains, bodies, and skin can advocate for themselves. Women who are told "it's just your hormones" and sent away without information or treatment cannot. The knowledge is the power — not the denial that hormones exist.

The same principle applies to men. Male hormonal health — testosterone decline, andropause, the skin and body changes of aging male biology — is systematically undertaught, undertreated, and surrounded by cultural pressure to ignore it. Men who understand their hormonal arc can make informed decisions. Men who are taught that hormonal acknowledgment is weakness cannot.

Hormones are real. They matter in every body. Understanding them serves everyone — and the withholding of that understanding has never served equality. It has served dismissal.

Few words are deployed more selectively or more unfairly than "hormonal" when applied to women.

A woman expresses frustration, grief, or strong conviction — she is told she is being hormonal. A man expresses identical emotions — he is being passionate, decisive, or direct. The same emotional content, the same neurobiological substrate, the same physiological arousal — labeled differently based entirely on the sex of the person experiencing it.

This is not a biological distinction. It is a cultural one — and it has no scientific basis.

The biology of emotion in every body: Emotions are not produced by hormones alone. They are the product of a complex interaction between:

• Neurobiological architecture — the structure and chemistry of the brain, which differs between individuals far more than between sexes
• Life experience and learned patterns — the emotional responses conditioned by a lifetime of experience
• Social context — the environment, relationships, and immediate situation
• Physiological state — hunger, sleep deprivation, pain, illness, and yes, hormonal state
• Cognitive interpretation — how the conscious mind frames and responds to physiological arousal

Hormones are one input into this system — a real and meaningful one, but one operating within a complex network rather than deterministically producing behavior. [1]

The double standard: Testosterone drives aggression, risk-taking, competitive behavior, and sexual motivation in men — documented, consistent, hormonal effects. Yet male aggression is rarely dismissed as "just testosterone." It is contextualized, sometimes excused, sometimes celebrated. The identical logic that pathologizes women's emotionality as hormonal instability would, applied consistently, pathologize men's aggression, impulsivity, and risk-taking as testosterone dysregulation. It is not applied consistently.

What the dismissal costs: When a woman's legitimate pain, fatigue, cognitive changes, or emotional distress is labeled "hormonal" and dismissed, real health conditions go undiagnosed. Perimenopause symptoms are undertreated for an average of several years because they are normalized and dismissed. Thyroid dysfunction — which affects women at 5-8 times the rate of men — is frequently missed because mood and energy changes are attributed to hormones rather than investigated. Premenstrual dysphoric disorder (PMDD) was not formally recognized as a medical condition until 2013.

The accurate statement: Hormonal changes produce real physiological effects — on mood, cognition, energy, skin, and body. These effects are worth understanding precisely because they are real. Dismissing them as instability or irrationality serves no one. Understanding them as biology — explainable, manageable, and deserving of medical attention — is what serves women. [1]

Hormones are chemical messengers — molecules produced by specialized glands and cells that travel through the bloodstream to target tissues, where they bind to receptors and regulate gene expression, cellular function, and physiological processes.

They are not on/off switches. They operate in gradients — higher and lower concentrations producing different magnitudes of effect. They interact with each other — the presence or absence of one hormone affects the sensitivity of receptors for another. They change across the day (cortisol peaks in the morning; melatonin peaks at night), across the menstrual cycle, across decades, and in response to experience, environment, and health.

The endocrine system — the network of glands and tissues that produce hormones — includes the hypothalamus, pituitary gland, thyroid, parathyroid glands, adrenal glands, pancreas, ovaries, and testes. It is regulated by feedback loops: the brain monitors circulating hormone levels and adjusts production signals up or down to maintain balance. [2]

This feedback system is elegant and robust — but it is also susceptible to disruption. Endocrine-disrupting chemicals, chronic stress, illness, aging, and medical treatment can all alter the system's calibration with downstream effects on every organ system it governs — including skin.

Estrogen (estradiol, estrone, estriol)

Produced primarily by the ovaries in women and in small amounts by the testes and adrenal glands in men. Regulates female reproductive development, the menstrual cycle, bone density, cardiovascular health, brain function, and skin biology. Declines dramatically at menopause in women; is present at low levels throughout male life. Affects skin through collagen synthesis, barrier lipid production, sebum modulation, melanocyte activity, and wound healing. [2]

Progesterone

Produced after ovulation by the corpus luteum; in pregnancy by the placenta. Counterbalances estrogen's proliferative effects, supports pregnancy, has calming (GABAergic) neurological effects, and acts as a mild diuretic. Declines in perimenopause as ovulation becomes less frequent. Absent in men at significant levels.

Testosterone

Produced by the testes in men and in smaller amounts by the ovaries and adrenal glands in women. The primary androgenic hormone — drives sebaceous gland activity, muscle maintenance, bone density, libido, and energy in both sexes. Declines gradually in men from the mid-thirties; fluctuates with the estrogen-testosterone balance in women throughout the reproductive years and postmenopause.

Cortisol

The primary stress hormone — produced by the adrenal cortex in response to HPA axis activation. Regulates metabolism, immune function, inflammation, and the stress response. In skin, excess cortisol suppresses ceramide synthesis, impairs wound healing, degrades collagen, and disrupts the microbiome. Follows a diurnal rhythm — peaks in the early morning, reaches its nadir overnight. [3]

Thyroid hormones (T3, T4)

Produced by the thyroid gland — regulate metabolic rate throughout the body. Affect skin through their influence on cell turnover, sebaceous activity, sweating, and hair follicle cycling. Hypothyroidism produces dry, thickened skin, hair loss, and slowed cell turnover; hyperthyroidism produces warm, moist skin, increased sweating, and sometimes hair thinning.

Growth hormone (GH) and IGF-1

GH is released in pulses — predominantly during deep sleep — and stimulates the liver to produce IGF-1. Together they drive growth during puberty and maintain muscle mass, bone density, and cellular repair throughout adult life. GH and IGF-1 decline progressively with age — one mechanism of the structural changes in aging skin.

OxytocinThe connection and bonding hormone — released in response to touch, intimacy, and positive social interaction. Has documented anti-inflammatory and anti-aging effects on skin through its suppression of the senescence-associated secretory phenotype (SASP) of aging fibroblasts. Declines with age and social isolation. Covered in depth in our Oxytocin and Skin guide. [3]

The female hormonal arc is characterized by dramatic transitions punctuated by periods of relative stability — and by a cyclical monthly rhythm during the reproductive years that produces regular, predictable variation overlaid on the longer lifecycle arc.

• Puberty (approximately 8-13 years):The hypothalamic-pituitary-gonadal axis activates, initiating the cascade that produces estrogen and androgen surges. Sebaceous glands enlarge and activate. The body transforms from a child's proportions to an adult female's through fat redistribution, breast development, and skeletal maturation. The brain reorganizes. The menstrual cycle begins. This is covered in depth in our Puberty and Skin — Girls guide.
• Reproductive years (approximately 13-45 years):Relative hormonal stability — cyclical but predictable. Estrogen and progesterone rise and fall in a monthly rhythm that governs the menstrual cycle and produces cyclical changes in skin, mood, energy, and libido. Estrogen's protective influence maintains collagen density, barrier function, and sebum balance through this period. Pregnancy and postpartum represent significant hormonal disruptions within this arc.
• Perimenopause (approximately 40-51 years):The most hormonally chaotic period of adult female life — erratic estrogen fluctuations, progesterone decline as ovulation becomes irregular, and the cascade of symptoms that follow. The transition that is often the most symptomatic and the most poorly supported by medical care. Covered in depth in our Perimenopause guide.
• Postmenopause (51 onward):The new stable baseline — consistently low estrogen, minimal progesterone, continued slow testosterone decline. Skin changes that began in perimenopause consolidate and continue at a slower rate. Covered in our Postmenopause and Skin guide.

The defining characteristic of female hormonal biology: The transition from reproductive to postmenopausal hormonal status is a cliff rather than a slope — a relatively rapid, dramatic change in the hormonal environment concentrated in a few years. This abruptness is why the perimenopausal transition is so symptomatic and why adaptation takes time. [2]

Male hormonal biology is systematically underacknowledged — in medical education, popular culture, and men's own self-understanding. The cultural narrative that men are not hormonal creatures is not only inaccurate; it actively prevents men from understanding and addressing real health changes that affect their quality of life, skin, and long-term wellbeing.

• Puberty (approximately 9-14 years):The testosterone surge of male puberty is more dramatic in its androgenic effects than female puberty — producing more pronounced sebaceous activation, more oiliness, and in many boys more significant blemish-prone skin than their female peers. Voice change, muscle development, and skeletal growth are direct testosterone effects. Covered in our Puberty and Skin — Boys guide — coming soon.
• Peak testosterone years (approximately 18-30 years):The hormonal baseline of young adult male biology — high testosterone, robust GH pulsing, thick collagen-dense skin, high sebum production, strong barrier function. Male skin at this stage ages more slowly in some respects than female skin of the same age — the higher baseline collagen density and sebum production provide protection that becomes noticeable in later decades.
• Gradual testosterone decline (30s onward):Testosterone declines at approximately 1-2% per year after age 30 — slower and more gradual than female estrogen decline at menopause, but cumulative over decades. This gradual decline produces progressive changes in energy, muscle mass, bone density, mood, libido, skin sebum production, and barrier function that many men attribute to "just getting older" without understanding the hormonal mechanism. This is andropause — a real phenomenon that deserves the same acknowledgment as menopause.

The slope rather than the cliff: Where female hormonal transition is a cliff — a relatively rapid drop — male hormonal decline is a slope. There is no equivalent of the menstrual cycle stopping to mark the transition clearly. The gradual nature of andropause means it is often unrecognized and untreated — which is not a biological advantage but a diagnostic challenge. [4]

Androgen deprivation therapy (ADT): For men with prostate cancer treated with ADT — which suppresses testosterone to near-zero levels — the experience is the closest male equivalent of surgical menopause. Hot flashes, skin dryness, bone density loss, muscle loss, and mood changes occur rapidly and dramatically. This represents the clearest demonstration of what testosterone does in male biology — its sudden absence makes its presence unmistakable. Covered in our Prostate Cancer, ADT, and Skin guide — coming soon.

Despite the different paths — the female cliff and the male slope — both sexes arrive at a similar destination in late life: very low sex hormones, thin and fragile skin, reduced sebum production, impaired wound healing, and the characteristic skin of advanced age.

The route matters — it produces different timelines and different intermediate experiences. But the endpoint biology has more in common than the divergent paths might suggest. This convergence is one of the most scientifically interesting aspects of hormonal aging — and one of the most underexplored. The late life skin care needs of women and men are more similar than the earlier decades of different hormonal biology might suggest.

Gender-affirming hormone therapy produces real, meaningful hormonal changes — and those changes have real, documented effects on skin and the body.

What we can say: Feminizing hormone therapy — typically estrogen combined with androgen-blocking medications — shifts the hormonal environment toward a female profile. The documented skin effects include reduced sebum production, reduced oiliness and blemish tendency, changes in skin texture and thickness, and reduced body and facial hair growth. These are the predictable consequences of reducing androgenic stimulation and increasing estrogenic influence on skin biology.

Masculinizing hormone therapy — testosterone — shifts the hormonal environment toward a male profile. The documented skin effects include increased sebum production, increased oiliness, potential development of blemish-prone skin, increased body and facial hair, and skin thickening over time. These are the predictable consequences of androgenic stimulation on sebaceous glands and skin structure.

What we cannot yet say with scientific rigor: The honest limitation of the current literature is that most studies examining hormones and skin were conducted in cisgender populations — and the relatively small sample sizes of studies specifically examining transgender individuals mean that the long-term, longitudinal data required to make specific, rigorous claims about skin aging trajectories, barrier function changes, and other nuanced outcomes in transgender people do not yet exist at the level required for the same scientific confidence we have in cisgender data.

This is not an absence of acknowledgment — it is an absence of data. The experience of transgender individuals using hormone therapy is real, their skin changes are real, and they deserve the same evidence-based guidance as everyone else. The current scientific literature has not yet produced that guidance at the sample sizes and longitudinal depths required for full confidence.

As the research matures — and it is growing — this content will grow with it. If you are transgender and navigating hormone therapy and skin changes, the general principles of how estrogen and testosterone affect skin biology provide a useful starting framework, while acknowledging that your individual experience may differ from the cisgender patterns the research currently describes most thoroughly. [5]

Every hormone discussed in this post has documented effects on skin — and every one of those hormonal effects can be disrupted by endocrine-disrupting chemicals (EDCs): compounds that mimic hormones, block hormone receptors, or interfere with hormone metabolism.

The skin implications of EDC exposure are direct:

• Estrogenic EDCs (parabens, certain UV filters, some phthalates) can mimic estrogen's effects on skin and on the broader hormonal system
• Anti-androgenic EDCs can reduce androgenic stimulation of sebaceous glands — potentially beneficial in some respects but operating outside the body's own hormonal regulation
• EDCs that affect thyroid function alter the metabolic environment in which skin cells operate
• EDCs that disrupt cortisol regulation affect the stress-barrier-skin relationship

The vulnerability to EDC disruption is greatest at hormonal transition points — puberty, pregnancy, perimenopause — when the hormonal system is actively recalibrating. This is why EDC-free skincare is not a wellness trend but a scientifically grounded health priority — particularly for the audiences whose hormonal systems are most actively in flux. [6]

Every Juventude product is cross-referenced against six independent safety databases for endocrine-disrupting compounds. No parabens, no phthalates, no oxybenzone, no confirmed hormone disruptors. That commitment reflects the understanding that skincare is not separate from hormonal health — it is a daily input into the chemical environment in which your hormonal system operates.